Drugs
1
in active trials
Trials
1 active
1 since 2021
Drugs1
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
In vivo CAR-T, mRNA in lipid nanoparticles, target not disclosed |
Early Phase 1 | 30 May 2027Early Phase 1 trial completes | |||
| How it works | Reprograms the patient's own immune T cells | ||||
| Next date | 30 May 2027 · Early Phase 1 trial completes | ||||
| Also tested for | Systemic Lupus Erythematosus, Autoimmune Hemolytic Anemia (AIHA) | ||||
| Open drug page | |||||
About
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 16 Nov 2026 Industry-sponsored drug trials since 2021